Similar articles

• Ventricular arrhythmias and changes in blood pressure and left ventricular mass induced by antihypertensive treatment in hypertensive patients.

  Malerba M, Muiesan ML, Zulli R, Rizzoni D, Calebich S, Agabiti-Rosei E. Malerba M, et al. J Hypertens Suppl. 1991 Dec;9(6):S162-3. J Hypertens Suppl. 1991. PMID: 1840186 No abstract available.
• Current issues in hypertension research and therapy.

  MacFadyen RJ, Prasad N. MacFadyen RJ, et al. Br J Hosp Med. 1995 Apr 5-18;53(7):335-43. Br J Hosp Med. 1995. PMID: 7788073 Review.
• Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.

  Fagard R, Staessen J, Thijs L, Van Hoof R, Amery A. Fagard R, et al. J Hypertens Suppl. 1993 Dec;11(6):S27-9. J Hypertens Suppl. 1993. PMID: 7909547 No abstract available.
• Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.

  Almazov VA, Shlyakhto EV, Konrady AO, Macsimova TA, Zaharov DV, Rudomanov OG. Almazov VA, et al. Med Sci Monit. 2000 Mar-Apr;6(2):309-13. Med Sci Monit. 2000. PMID: 11208328
• Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.

  Palmieri V, Devereux RB. Palmieri V, et al. Minerva Cardioangiol. 2002 Jun;50(3):169-74. Minerva Cardioangiol. 2002. PMID: 12107398 Review.